With the analysis among 547 patents, we discovered top 93 key players by total patent application. DRAGONFLY Therapeutics, Inc., Xyphos Biosciences, Inc., Novo Nordisk A/S are dominant in this area. They take 48.81% of the total patent filing.
DRAGONFLY Therapeutics, Inc.
Massachusetts, United States
Patent: 182
California, United States
Patent: 58
Hovedstaden, Denmark
Patent: 27
Basel-Stadt, Switzerland
Patent: 22
California, United States
Patent: 15
Regents of the University of California
California, United States
Patent: 12
Nanjing Legend Biotechnology Co., Ltd.
Jiangsu Sheng, China
Patent: 12
Novelogics Biotechnology, Inc.
Ohio State Innovation Foundation
Ohio, United States
Patent: 7
Guangdong Sheng, China
Patent: 7
With the analysis among 255 patents, we discovered top 7 start-ups by total patent application. DRAGONFLY Therapeutics, Inc., Xyphos Biosciences, Inc., Institut National de la Santé et de la Recherche Médicale are active in this area.
DRAGONFLY Therapeutics, Inc.
Massachusetts, United States
Patent: 182
California, United States
Patent: 58
Institut National de la Santé et de la Recherche Médicale
Cytoimmune Therapeutics, Inc.
California, United States
Patent: 5
Fosun Kite Biotechnology Co. Ltd.
Shanghai Shi, China
Patent: 1
Missouri, United States
Patent: 1
With the analysis among related 476 patents applied in the last 5 years. We discover 109 most active companies in this area. The fast-growing DRAGONFLY Therapeutics, Inc., Xyphos Biosciences, Inc., Novartis AG take 50.63% of patent filing during this period.
DRAGONFLY Therapeutics, Inc.
Massachusetts, United States
Patent: 182
California, United States
Patent: 37
Basel-Stadt, Switzerland
Patent: 22
National University of Singapore
Central Region, Singapore
Patent: 17
California, United States
Patent: 15
Nanjing Legend Biotechnology Co., Ltd.
Jiangsu Sheng, China
Patent: 11
Guangdong Sheng, China
Patent: 7
The J. David Gladstone Institutes
California, United States
Patent: 7
H. Lee Moffitt Cancer Center & Research Institute, Inc.
Dana-Farber Cancer Institute, Inc.
Massachusetts, United States
Patent: 7
With the analysis among related 476 patents in last 5 years, we discover 93 new entrants. DRAGONFLY Therapeutics, Inc., Novartis AG, Nkarta, Inc. are the most active new entrants in this area.
DRAGONFLY Therapeutics, Inc.
Massachusetts, United States
Patent: 182
Basel-Stadt, Switzerland
Patent: 22
California, United States
Patent: 15
Guangdong Sheng, China
Patent: 7
The J. David Gladstone Institutes
California, United States
Patent: 7
H. Lee Moffitt Cancer Center & Research Institute, Inc.
California, United States
Patent: 5
Cytoimmune Therapeutics, Inc.
California, United States
Patent: 5
Illinois, United States
Patent: 5
Massachusetts, United States
Patent: 4
With the analysis among 205 patents, we discovered top 31 universities and scientific research institutions by total patent application. National University of Singapore, Northwestern University, Washington University in St. Louis are dominant in this area. They take 43.41% of the total patent filing.
National University of Singapore
Central Region, Singapore
Patent: 23
Illinois, United States
Patent: 5
Washington University in St. Louis
Missouri, United States
Patent: 5
Niedersachsen, Germany
Patent: 5
China Pharmaceutical University
Jiangsu Sheng, China
Patent: 5
The Trustees of Columbia University in The City of New York
New York, United States
Patent: 3
Eberhard Karls Universität Tübingen
Baden-Württemberg, Germany
Patent: 3
Université Claude Bernard Lyon 1
Université d'Aix-Marseille
East China Normal University
Shanghai Shi, China
Patent: 3